Skip to main content

Peer Review reports

From: Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy

Original Submission
20 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Jul 2023 Reviewed Reviewer Report
12 Sep 2023 Reviewed Reviewer Report
27 Sep 2023 Author responded Author comments - Soha Gomaa
Resubmission - Version 4
27 Sep 2023 Submitted Manuscript version 4
29 Sep 2023 Author responded Author comments - Soha Gomaa
Resubmission - Version 5
29 Sep 2023 Submitted Manuscript version 5
2 Oct 2023 Author responded Author comments - Soha Gomaa
Resubmission - Version 6
2 Oct 2023 Submitted Manuscript version 6
3 Nov 2023 Reviewed Reviewer Report
6 Nov 2023 Reviewed Reviewer Report
24 Nov 2023 Author responded Author comments - Soha Gomaa
Resubmission - Version 7
24 Nov 2023 Submitted Manuscript version 7
Publishing
4 Dec 2023 Editorially accepted
4 Jan 2024 Article published 10.1186/s12885-023-11714-4

You can find further information about peer review here.

Back to article page